Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial.
Ströhlein MA, Lordick F, Rüttinger D, Grützner KU, Schemanski OC, Jäger M, Lindhofer H, Hennig M, Jauch KW, Peschel C, Heiss MM. Ströhlein MA, et al. Among authors: heiss mm. Onkologie. 2011;34(3):101-8. doi: 10.1159/000324667. Epub 2011 Feb 18. Onkologie. 2011. PMID: 21358214 Clinical Trial.
The current status of immunotherapy in peritoneal carcinomatosis.
Ströhlein MA, Heiss MM, Jauch KW. Ströhlein MA, et al. Among authors: heiss mm. Expert Rev Anticancer Ther. 2016 Oct;16(10):1019-27. doi: 10.1080/14737140.2016.1224666. Epub 2016 Aug 25. Expert Rev Anticancer Ther. 2016. PMID: 27530056 Review.
Immunotherapy of peritoneal carcinomatosis.
Ströhlein MA, Heiss MM. Ströhlein MA, et al. Among authors: heiss mm. Cancer Treat Res. 2007;134:483-91. doi: 10.1007/978-0-387-48993-3_33. Cancer Treat Res. 2007. PMID: 17633076 Review.
132 results